Cargando…

The Traditional Chinese Medicine Gedan Jiangya Decoction Alleviates Left Ventricular Hypertrophy via Suppressing the Ras/ERK1/2 Signaling Pathway

Gedan Jiangya Decoction (GJD), a Chinese herbal medicine composed of six botanical medicines, was designed to treat hypertension (patent published number (CN114246896A)). The overexpression of the ERK (extracellular signal-regulated kinase) signaling pathway is essential in developing left ventricul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammed, Shadi A. D., Liu, Hanxing, Baldi, Salem, Chen, Pingping, Wang, Yu, Lu, Fang, Liu, Shumin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699742/ https://www.ncbi.nlm.nih.gov/pubmed/36437833 http://dx.doi.org/10.1155/2022/6924197

Ejemplares similares

Network Pharmacology and Molecular Docking-Based Mechanism Study to Reveal Antihypertensive Effect of Gedan Jiangya Decoction
por: Liu, Hanxing, et al.
Publicado: (2022)

Network Pharmacology Prediction and Pharmacological Verification Mechanism of Yeju Jiangya Decoction on Hypertension
por: Wang, Ting, et al.
Publicado: (2021)

GJD Modulates Cardiac/Vascular Inflammation and Decreases Blood Pressure in Hypertensive Rats
por: Mohammed, Shadi A. D., et al.
Publicado: (2022)

Antihypertensive, antioxidant, and renal protective impact of integrated GJD with captopril in spontaneously hypertensive rats
por: Mohammed, Shadi A. D., et al.
Publicado: (2023)

Qingxuan Jiangya Decoction Reverses Vascular Remodeling by Inducing Vascular Smooth Muscle Cell Apoptosis in Spontaneously Hypertensive Rats
por: Xiao, Fei, et al.
Publicado: (2016)

Qingxuan Jiangya Decoction Mitigates Renal Interstitial Fibrosis in Spontaneously Hypertensive Rats by Regulating Transforming Growth Factor-β1/Smad Signaling Pathway
por: Liu, Wangyu, et al.
Publicado: (2017)

Identification of Tengfu Jiangya Tablet Target Biomarkers with Quantitative Proteomic Technique
por: Xu, Jingwen, et al.
Publicado: (2017)

The Renal Protective Effect of Jiangya Tongluo Formula, through Regulation of Adrenomedullin and Angiotensin II, in Rats with Hypertensive Nephrosclerosis
por: Han, Lin, et al.
Publicado: (2015)

Ras-ERK-ETS inhibition alleviates neuronal mitochondrial dysfunction by reprogramming mitochondrial retrograde signaling
por: Duncan, Olivia F., et al.
Publicado: (2018)

Application of Zebrafish Model in the Suppression of Drug-Induced Cardiac Hypertrophy by Traditional Indian Medicine Yogendra Ras
por: Balkrishna, Acharya, et al.
Publicado: (2020)

RAS Dimers: The Novice Couple at the RAS-ERK Pathway Ball
por: Herrero, Ana, et al.
Publicado: (2021)

Effects of Bushen-Jiangya granules on blood pressure and pharmacogenomic evaluation in low-to-medium-risk hypertensive patients: study protocol for a randomized double-blind controlled trial
por: Yang, Xiaochen, et al.
Publicado: (2022)

Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway
por: Cai, Fei-Fei, et al.
Publicado: (2018)

Efficacy and safety of Tengfu Jiangya tablet combined with valsartan/amlodipine in the treatment of stage 2 hypertension: study protocol for a randomized controlled trial
por: Wang, Yu, et al.
Publicado: (2022)

A computationally engineered RAS rheostat reveals RAS/ERK signaling dynamics
por: Rose, John C., et al.
Publicado: (2016)

PKC translocation and ERK1/2 activation in compensated right ventricular hypertrophy secondary to chronic emphysema.
por: Avelar, Erick, et al.
Publicado: (2005)

Jiawei Xianglian Decoction (JWXLD), a Traditional Chinese Medicine (TCM), Alleviates CPT-11-Induced Diarrhea in Mice
por: Lu, Jinhua, et al.
Publicado: (2020)

Study on Supramolecules in Traditional Chinese Medicine Decoction
por: Gao, Yuan, et al.
Publicado: (2022)

Ras Downstream Effector GGCT Alleviates Oncogenic Stress
por: He, Zaoke, et al.
Publicado: (2019)

Moexipril and left ventricular hypertrophy
por: Chrysant, George S, et al.
Publicado: (2007)

Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013)

ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
por: Gallo, Simona, et al.
Publicado: (2019)

Dangshen Erling Decoction Ameliorates Myocardial Hypertrophy via Inhibiting Myocardial Inflammation
por: Zhong, Yigang, et al.
Publicado: (2022)

HuangQi ChiFeng decoction maintains gut microbiota and bile acid homeostasis through FXR signaling to improve atherosclerosis
por: Fu, Jiaqi, et al.
Publicado: (2023)

Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers
por: Bacharova, Ljuba, et al.
Publicado: (2023)

Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats
por: Xiong, Xingjiang, et al.
Publicado: (2017)

Ras–ERK Signaling in Behavior: Old Questions and New Perspectives
por: Fasano, Stefania, et al.
Publicado: (2011)

Comparisons of traditional electrocardiographic criteria for left and right ventricular hypertrophy in young Asian women: The CHIEF heart study
por: Su, Fang-Ying, et al.
Publicado: (2020)

Myocardial Energetics in Left Ventricular Hypertrophy
por: Jameel, Mohammad N, et al.
Publicado: (2009)

Isolated Right Ventricular Apical Hypertrophy
por: Yamashita, Kentaro, et al.
Publicado: (2020)

CARD9 mediates Dectin-1–induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity
por: Jia, Xin-Ming, et al.
Publicado: (2014)

Mulberry polyphenol extracts attenuated senescence through inhibition of Ras/ERK via promoting Ras degradation in VSMC
por: Chen, Ching-Pei, et al.
Publicado: (2022)

Effects of Yiqi Huoxue Decoction on Post-Myocardial Infarction Cardiac Nerve Remodeling and Cardiomyocyte Hypertrophy in Rats
por: Wang, Hui, et al.
Publicado: (2021)

Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation
por: Su, Congping, et al.
Publicado: (2019)

The metastasis suppressor Nm23 as a modulator of Ras/ERK signaling
por: Takács-Vellai, Krisztina
Publicado: (2014)

The Ras-Erk-ETS-Signaling Pathway Is a Drug Target for Longevity
por: Slack, Cathy, et al.
Publicado: (2015)

Integrator orchestrates RAS/ERK1/2 signaling transcriptional programs
por: Yue, Jingyin, et al.
Publicado: (2017)

Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras
por: Frodyma, Danielle, et al.
Publicado: (2017)

Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
por: Gonzalez-Hormazabal, Patricio, et al.
Publicado: (2018)

Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
por: Gillies, Taryn E, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_73fcump3vb0tviuk4jgu79klsi